APOE and type 2 diabetes mellitus: In a recent study involving approximately 2,000 patients with T2D, metformin use was associated with better memory performance over time and dipeptidyl peptidase-4 (DDP-4) inhibitors slowed the rate of memory decline with the greatest benefit in APOE4 carriers (Wu et al., 2020).